Literature DB >> 27001151

Chromosomal Instability Affects the Tumorigenicity of Glioblastoma Tumor-Initiating Cells.

Kristina M Godek1, Monica Venere2, Quilian Wu2, Kevin D Mills3, William F Hickey4, Jeremy N Rich5, Duane A Compton6.   

Abstract

UNLABELLED: Tumors are dynamic organs that evolve during disease progression with genetic, epigenetic, and environmental differences among tumor cells serving as the foundation for selection and evolution in tumors. Tumor-initiating cells (TIC) that are responsible for tumorigenesis are a source of functional cellular heterogeneity, whereas chromosomal instability (CIN) is a source of karyotypic genetic diversity. However, the extent that CIN contributes to TIC genetic diversity and its relationship to TIC function remains unclear. Here, we demonstrate that glioblastoma TICs display CIN with lagging chromosomes at anaphase and extensive nonclonal chromosome copy-number variations. Elevating the basal chromosome missegregation rate in TICs decreases both proliferation and the stem-like phenotype of TICs in vitro Consequently, tumor formation is abolished in an orthotopic mouse model. These results demonstrate that TICs generate genetic heterogeneity within tumors, but that TIC function is impaired if the rate of genetic change is elevated above a tolerable threshold. SIGNIFICANCE: Genetic heterogeneity among TICs may produce advantageous karyotypes that lead to therapy resistance and relapse; however, we found that TICs have an upper tolerable limit for CIN. Thus, increasing the chromosome missegregation rate offers a new therapeutic strategy to eliminate TICs from tumors. Cancer Discov; 6(5); 532-45. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 461. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27001151      PMCID: PMC4854766          DOI: 10.1158/2159-8290.CD-15-1154

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  50 in total

1.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

Authors:  Ruihuan Chen; Merry C Nishimura; Stephanie M Bumbaca; Samir Kharbanda; William F Forrest; Ian M Kasman; Joan M Greve; Robert H Soriano; Laurie L Gilmour; Celina Sanchez Rivers; Zora Modrusan; Serban Nacu; Steve Guerrero; Kyle A Edgar; Jeffrey J Wallin; Katrin Lamszus; Manfred Westphal; Susanne Heim; C David James; Scott R VandenBerg; Joseph F Costello; Scott Moorefield; Cynthia J Cowdrey; Michael Prados; Heidi S Phillips
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

2.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

Authors:  Yifang Hu; Gordon K Smyth
Journal:  J Immunol Methods       Date:  2009-06-28       Impact factor: 2.303

3.  Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder.

Authors:  Katherine I Oravecz-Wilson; Steven T Philips; Omer H Yilmaz; Heather M Ames; Lina Li; Brendan D Crawford; Alice M Gauvin; Peter C Lucas; Kajal Sitwala; James R Downing; Sean J Morrison; Theodora S Ross
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

4.  Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells.

Authors:  Aniek Janssen; Geert J P L Kops; René H Medema
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-23       Impact factor: 11.205

5.  Deviant kinetochore microtubule dynamics underlie chromosomal instability.

Authors:  Samuel F Bakhoum; Giulio Genovese; Duane A Compton
Journal:  Curr Biol       Date:  2009-10-29       Impact factor: 10.834

6.  The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma.

Authors:  Monica Venere; Craig Horbinski; James F Crish; Xun Jin; Amit Vasanji; Jennifer Major; Amy C Burrows; Cathleen Chang; John Prokop; Quilian Wu; Peter A Sims; Peter Canoll; Matthew K Summers; Steven S Rosenfeld; Jeremy N Rich
Journal:  Sci Transl Med       Date:  2015-09-09       Impact factor: 17.956

7.  Proliferation of aneuploid human cells is limited by a p53-dependent mechanism.

Authors:  Sarah L Thompson; Duane A Compton
Journal:  J Cell Biol       Date:  2010-02-01       Impact factor: 10.539

Review 8.  How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.

Authors:  M Gerlinger; C Swanton
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

9.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.

Authors:  Steven M Pollard; Koichi Yoshikawa; Ian D Clarke; Davide Danovi; Stefan Stricker; Roslin Russell; Jane Bayani; Renee Head; Marco Lee; Mark Bernstein; Jeremy A Squire; Austin Smith; Peter Dirks
Journal:  Cell Stem Cell       Date:  2009-06-05       Impact factor: 24.633

10.  SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.

Authors:  Myung Jin Son; Kevin Woolard; Do-Hyun Nam; Jeongwu Lee; Howard A Fine
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

View more
  26 in total

1.  FHL3 links cell growth and self-renewal by modulating SOX4 in glioma.

Authors:  Wei Han; Peishan Hu; Fan Wu; Shanshan Wang; Yan Hu; Shanshan Li; Tao Jiang; Boqin Qiang; Xiaozhong Peng
Journal:  Cell Death Differ       Date:  2018-06-28       Impact factor: 15.828

Review 2.  Mutant ATRX: uncovering a new therapeutic target for glioma.

Authors:  Santiago Haase; María Belén Garcia-Fabiani; Stephen Carney; David Altshuler; Felipe J Núñez; Flor M Méndez; Fernando Núñez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

3.  Chromosomal instability suppresses the growth of K-Ras-induced lung adenomas.

Authors:  Christopher D Laucius; Bernardo Orr; Duane A Compton
Journal:  Cell Cycle       Date:  2019-06-24       Impact factor: 4.534

4.  IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.

Authors:  Felipe J Núñez; Flor M Mendez; Padma Kadiyala; Mahmoud S Alghamri; Masha G Savelieff; Maria B Garcia-Fabiani; Santiago Haase; Carl Koschmann; Anda-Alexandra Calinescu; Neha Kamran; Meghna Saxena; Rohin Patel; Stephen Carney; Marissa Z Guo; Marta Edwards; Mats Ljungman; Tingting Qin; Maureen A Sartor; Rebecca Tagett; Sriram Venneti; Jacqueline Brosnan-Cashman; Alan Meeker; Vera Gorbunova; Lili Zhao; Daniel M Kremer; Li Zhang; Costas A Lyssiotis; Lindsey Jones; Cameron J Herting; James L Ross; Dolores Hambardzumyan; Shawn Hervey-Jumper; Maria E Figueroa; Pedro R Lowenstein; Maria G Castro
Journal:  Sci Transl Med       Date:  2019-02-13       Impact factor: 17.956

Review 5.  Determinants and clinical implications of chromosomal instability in cancer.

Authors:  Laurent Sansregret; Bart Vanhaesebroeck; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2018-01-03       Impact factor: 66.675

6.  Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/CCDH1 Activity and Pharmacologic Inhibition of APC/CCDH1/CDC20 Compromises Viability.

Authors:  Kuntal De; Treg M Grubb; Abigail A Zalenski; Kayla E Pfaff; Debjani Pal; Shubhra Majumder; Matthew K Summers; Monica Venere
Journal:  Mol Cancer Res       Date:  2019-04-29       Impact factor: 5.852

7.  TET1 regulates DNA repair in human glial cells.

Authors:  Katherine J Kuhns; Hernando Lopez-Bertoni; Jonathan B Coulter; Joseph P Bressler
Journal:  Toxicol Appl Pharmacol       Date:  2019-07-03       Impact factor: 4.219

8.  Tissue stem cells: the new actors in the aneuploidy field.

Authors:  Rita Brás; Claudio E Sunkel; Luís Pedro Resende
Journal:  Cell Cycle       Date:  2019-07-01       Impact factor: 4.534

Review 9.  The dual functions of Rab11 and Rab35 GTPases-regulation of cell division and promotion of tumorigenicity.

Authors:  Paulius Gibieža; Vilma Petrikaitė
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

10.  PAF promotes stemness and radioresistance of glioma stem cells.

Authors:  Derrick Sek Tong Ong; Baoli Hu; Yan Wing Ho; Charles-Etienne Gabriel Sauvé; Christopher A Bristow; Qianghu Wang; Asha S Multani; Peiwen Chen; Luigi Nezi; Shan Jiang; Claire Elizabeth Gorman; Marta Moreno Monasterio; Dimpy Koul; Matteo Marchesini; Simona Colla; Eun-Jung Jin; Erik P Sulman; Denise J Spring; Wai-Kwan Alfred Yung; Roel G W Verhaak; Lynda Chin; Y Alan Wang; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.